&Partners’s T2 Biosystems, Inc TTOO Stock Holding History

&Partners’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5	Closed	-$63K	–	168
2019 Q3	$63K	Hold	5	–	–	0.08%	148
2019 Q2	$42K	Buy	5 +3	+150%	+$35.1K	0.06%	148
2019 Q1	$26K	Buy	+2	New	+$34K	0.04%	145

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

&Partners's TTOO Position: Q4 2019 in Review

&Partners sold out of T2 Biosystems, Inc (TTOO) in Q4 2019, closing a stake of 5 shares — an estimated $63K sold.

&Partners first reported a position in TTOO in Q1 2019 and held it in 3 quarters. The position peaked at $63K in Q3 2019. 43 funds tracked by Wall St. Rank hold TTOO as of Q4 2019.

&Partners reported no remaining T2 Biosystems, Inc position as of Q4 2019 after selling out during the quarter.
&Partners sold 5 T2 Biosystems, Inc shares in Q4 2019, an estimated $63K.
&Partners first reported a position in T2 Biosystems, Inc in Q1 2019 and held it in 3 quarters.
&Partners's T2 Biosystems, Inc position peaked at $63K in Q3 2019.
43 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2019.

Based on &Partners's 13F filing for Q4 2019, filed 10 Jan 2020.